| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pain, Postoperative | 25 | 2019 | 26 | 6.980 |
Why?
|
| Female | 73 | 2020 | 1048 | 4.370 |
Why?
|
| Anesthesiology | 11 | 2019 | 12 | 4.270 |
Why?
|
| Humans | 84 | 2019 | 2066 | 4.190 |
Why?
|
| Nerve Block | 9 | 2018 | 13 | 3.270 |
Why?
|
| Adult | 48 | 2019 | 602 | 3.130 |
Why?
|
| Anesthetics, Local | 12 | 2018 | 20 | 3.050 |
Why?
|
| Middle Aged | 42 | 2019 | 544 | 2.900 |
Why?
|
| Analgesics, Opioid | 18 | 2018 | 21 | 2.850 |
Why?
|
| Ambulatory Surgical Procedures | 8 | 2018 | 10 | 2.720 |
Why?
|
| Male | 43 | 2019 | 1130 | 2.500 |
Why?
|
| Internship and Residency | 8 | 2019 | 48 | 2.490 |
Why?
|
| Postoperative Complications | 7 | 2017 | 30 | 2.160 |
Why?
|
| Laparoscopy | 6 | 2014 | 9 | 2.140 |
Why?
|
| Randomized Controlled Trials as Topic | 10 | 2015 | 43 | 2.050 |
Why?
|
| Treatment Outcome | 24 | 2018 | 133 | 2.020 |
Why?
|
| Anesthesia | 7 | 2015 | 9 | 1.940 |
Why?
|
| Analgesia, Epidural | 7 | 2018 | 8 | 1.840 |
Why?
|
| Double-Blind Method | 20 | 2018 | 37 | 1.760 |
Why?
|
| Aged | 25 | 2019 | 461 | 1.660 |
Why?
|
| Lidocaine | 5 | 2017 | 9 | 1.640 |
Why?
|
| Anesthetics, Inhalation | 4 | 2017 | 7 | 1.540 |
Why?
|
| Dexamethasone | 5 | 2015 | 7 | 1.520 |
Why?
|
| Gynecologic Surgical Procedures | 4 | 2017 | 4 | 1.520 |
Why?
|
| Analgesia, Obstetrical | 7 | 2017 | 8 | 1.510 |
Why?
|
| Arthroplasty, Replacement, Knee | 4 | 2018 | 14 | 1.500 |
Why?
|
| Prospective Studies | 21 | 2018 | 126 | 1.490 |
Why?
|
| Pain Measurement | 14 | 2017 | 27 | 1.470 |
Why?
|
| Laryngeal Masks | 3 | 2017 | 4 | 1.430 |
Why?
|
| Sciatic Nerve | 4 | 2015 | 4 | 1.420 |
Why?
|
| Amides | 3 | 2016 | 3 | 1.370 |
Why?
|
| Dog Diseases | 5 | 2018 | 5 | 1.320 |
Why?
|
| Bupivacaine | 5 | 2018 | 6 | 1.260 |
Why?
|
| Cats | 3 | 2013 | 7 | 1.260 |
Why?
|
| Isoflurane | 3 | 2013 | 3 | 1.250 |
Why?
|
| Time Factors | 18 | 2019 | 149 | 1.220 |
Why?
|
| Pain Management | 7 | 2018 | 15 | 1.200 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2019 | 77 | 1.150 |
Why?
|
| Propofol | 4 | 2017 | 4 | 1.140 |
Why?
|
| Retrospective Studies | 20 | 2019 | 118 | 1.140 |
Why?
|
| Anesthetics, Intravenous | 3 | 2017 | 3 | 1.100 |
Why?
|
| Anesthesia, General | 3 | 2017 | 4 | 1.060 |
Why?
|
| Analgesics, Non-Narcotic | 2 | 2017 | 5 | 1.060 |
Why?
|
| Acetaminophen | 2 | 2017 | 6 | 1.050 |
Why?
|
| Perioperative Care | 4 | 2015 | 4 | 1.050 |
Why?
|
| Cesarean Section | 5 | 2018 | 6 | 1.040 |
Why?
|
| Mastectomy, Segmental | 2 | 2017 | 3 | 1.020 |
Why?
|
| Methyl Ethers | 3 | 2017 | 3 | 1.020 |
Why?
|
| Anesthesia, Epidural | 2 | 2016 | 2 | 1.010 |
Why?
|
| Delivery, Obstetric | 3 | 2015 | 4 | 1.000 |
Why?
|
| Population Control | 3 | 2013 | 3 | 0.970 |
Why?
|
| Hypnotics and Sedatives | 2 | 2015 | 4 | 0.970 |
Why?
|
| Ketamine | 2 | 2015 | 5 | 0.970 |
Why?
|
| Epinephrine | 2 | 2016 | 8 | 0.900 |
Why?
|
| Organization and Administration | 2 | 2015 | 2 | 0.900 |
Why?
|
| Magnesium | 3 | 2013 | 19 | 0.880 |
Why?
|
| Hysterectomy | 3 | 2013 | 3 | 0.880 |
Why?
|
| Patient Safety | 2 | 2015 | 4 | 0.870 |
Why?
|
| Models, Biological | 2 | 2013 | 101 | 0.840 |
Why?
|
| Surveys and Questionnaires | 8 | 2017 | 109 | 0.840 |
Why?
|
| Pregnancy | 14 | 2018 | 38 | 0.830 |
Why?
|
| Anesthesia Recovery Period | 3 | 2017 | 3 | 0.780 |
Why?
|
| Health Literacy | 3 | 2018 | 7 | 0.780 |
Why?
|
| Postoperative Nausea and Vomiting | 4 | 2018 | 4 | 0.780 |
Why?
|
| Erythrocyte Transfusion | 2 | 2018 | 2 | 0.750 |
Why?
|
| Recovery of Function | 4 | 2014 | 7 | 0.750 |
Why?
|
| Elective Surgical Procedures | 2 | 2018 | 3 | 0.740 |
Why?
|
| Hospitals, Maternity | 2 | 2018 | 2 | 0.740 |
Why?
|
| Dogs | 7 | 2018 | 57 | 0.730 |
Why?
|
| Hysteroscopy | 2 | 2018 | 2 | 0.730 |
Why?
|
| Chronic Pain | 7 | 2018 | 12 | 0.720 |
Why?
|
| Intraoperative Care | 4 | 2017 | 4 | 0.680 |
Why?
|
| Fentanyl | 5 | 2018 | 5 | 0.680 |
Why?
|
| Animals | 14 | 2020 | 760 | 0.670 |
Why?
|
| Patients | 2 | 2018 | 4 | 0.650 |
Why?
|
| Postpartum Hemorrhage | 2 | 2016 | 2 | 0.640 |
Why?
|
| Analgesics | 3 | 2016 | 8 | 0.630 |
Why?
|
| Body Mass Index | 2 | 2017 | 37 | 0.630 |
Why?
|
| Decision Making | 1 | 2018 | 14 | 0.620 |
Why?
|
| Propanolamines | 1 | 2018 | 2 | 0.620 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2018 | 3 | 0.620 |
Why?
|
| Blood Transfusion, Autologous | 1 | 2018 | 1 | 0.620 |
Why?
|
| Operative Blood Salvage | 1 | 2018 | 1 | 0.620 |
Why?
|
| Kidney Neoplasms | 1 | 2018 | 8 | 0.620 |
Why?
|
| Faculty, Medical | 2 | 2019 | 24 | 0.610 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2018 | 21 | 0.610 |
Why?
|
| Morphine | 4 | 2014 | 6 | 0.610 |
Why?
|
| Adjuvants, Anesthesia | 2 | 2015 | 2 | 0.610 |
Why?
|
| Anesthetics | 4 | 2014 | 5 | 0.610 |
Why?
|
| Journal Impact Factor | 2 | 2015 | 4 | 0.600 |
Why?
|
| United States | 7 | 2016 | 156 | 0.580 |
Why?
|
| Incidence | 7 | 2017 | 45 | 0.570 |
Why?
|
| Patient Positioning | 1 | 2017 | 2 | 0.570 |
Why?
|
| Pharynx | 1 | 2017 | 2 | 0.570 |
Why?
|
| Larynx | 1 | 2017 | 3 | 0.570 |
Why?
|
| Ultrasonography, Interventional | 2 | 2016 | 12 | 0.560 |
Why?
|
| Aged, 80 and over | 7 | 2018 | 230 | 0.540 |
Why?
|
| Knee Joint | 1 | 2016 | 15 | 0.540 |
Why?
|
| Placenta Accreta | 1 | 2016 | 1 | 0.530 |
Why?
|
| Prenatal Diagnosis | 1 | 2016 | 2 | 0.530 |
Why?
|
| Medical Errors | 2 | 2013 | 4 | 0.520 |
Why?
|
| Physicians | 2 | 2013 | 16 | 0.520 |
Why?
|
| Clinical Competence | 2 | 2013 | 21 | 0.520 |
Why?
|
| Chicago | 6 | 2016 | 62 | 0.520 |
Why?
|
| Job Application | 1 | 2016 | 1 | 0.510 |
Why?
|
| Leiomyoma | 1 | 2016 | 1 | 0.510 |
Why?
|
| Uterine Artery Embolization | 1 | 2016 | 1 | 0.510 |
Why?
|
| Marfan Syndrome | 1 | 2015 | 1 | 0.510 |
Why?
|
| Monitoring, Intraoperative | 2 | 2015 | 4 | 0.510 |
Why?
|
| Registries | 1 | 2015 | 12 | 0.500 |
Why?
|
| Anesthesia, Obstetrical | 1 | 2015 | 1 | 0.500 |
Why?
|
| Parturition | 1 | 2015 | 1 | 0.500 |
Why?
|
| Patient Preference | 1 | 2015 | 1 | 0.500 |
Why?
|
| Post-Dural Puncture Headache | 1 | 2015 | 2 | 0.500 |
Why?
|
| Neostigmine | 1 | 2015 | 2 | 0.500 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2015 | 2 | 0.500 |
Why?
|
| Consciousness Monitors | 1 | 2015 | 1 | 0.500 |
Why?
|
| Drug Substitution | 1 | 2015 | 2 | 0.500 |
Why?
|
| Periodicals as Topic | 1 | 2015 | 7 | 0.500 |
Why?
|
| Patient Admission | 1 | 2015 | 1 | 0.500 |
Why?
|
| Perception | 1 | 2015 | 8 | 0.500 |
Why?
|
| Health Services Accessibility | 1 | 2015 | 8 | 0.490 |
Why?
|
| Mastectomy | 4 | 2017 | 4 | 0.490 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 11 | 0.490 |
Why?
|
| Pain | 1 | 2015 | 27 | 0.490 |
Why?
|
| Cross-Sectional Studies | 7 | 2018 | 67 | 0.490 |
Why?
|
| Esophageal Perforation | 1 | 2015 | 1 | 0.480 |
Why?
|
| Magnets | 1 | 2015 | 1 | 0.480 |
Why?
|
| Foreign Bodies | 1 | 2015 | 7 | 0.480 |
Why?
|
| Midazolam | 1 | 2014 | 1 | 0.480 |
Why?
|
| Hypoventilation | 1 | 2014 | 19 | 0.470 |
Why?
|
| Obesity, Morbid | 1 | 2014 | 2 | 0.450 |
Why?
|
| Bariatric Surgery | 1 | 2014 | 3 | 0.450 |
Why?
|
| Punctures | 1 | 2014 | 1 | 0.450 |
Why?
|
| Radial Artery | 1 | 2014 | 1 | 0.450 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2017 | 5 | 0.450 |
Why?
|
| Outpatients | 1 | 2013 | 2 | 0.440 |
Why?
|
| Catheterization, Peripheral | 1 | 2014 | 8 | 0.440 |
Why?
|
| Reproducibility of Results | 7 | 2019 | 69 | 0.440 |
Why?
|
| Respiration Disorders | 1 | 2013 | 1 | 0.440 |
Why?
|
| Dose-Response Relationship, Drug | 9 | 2017 | 61 | 0.430 |
Why?
|
| Breast Neoplasms | 5 | 2017 | 12 | 0.430 |
Why?
|
| Magnesium Compounds | 1 | 2013 | 1 | 0.430 |
Why?
|
| Pyrazoles | 1 | 2013 | 3 | 0.430 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2013 | 3 | 0.430 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 10 | 0.430 |
Why?
|
| Burnout, Professional | 1 | 2013 | 5 | 0.420 |
Why?
|
| Depression | 1 | 2013 | 31 | 0.420 |
Why?
|
| Antiemetics | 1 | 2012 | 2 | 0.410 |
Why?
|
| Biomedical Research | 1 | 2012 | 8 | 0.410 |
Why?
|
| Osteoarthritis | 1 | 2013 | 42 | 0.410 |
Why?
|
| School Admission Criteria | 1 | 2012 | 1 | 0.400 |
Why?
|
| Data Interpretation, Statistical | 4 | 2013 | 9 | 0.400 |
Why?
|
| Personnel Selection | 1 | 2012 | 4 | 0.400 |
Why?
|
| Logistic Models | 5 | 2015 | 27 | 0.400 |
Why?
|
| Femoral Nerve | 1 | 2012 | 1 | 0.400 |
Why?
|
| Analgesia | 1 | 2012 | 3 | 0.400 |
Why?
|
| Coronary Artery Bypass | 1 | 2012 | 1 | 0.400 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2012 | 15 | 0.390 |
Why?
|
| Publication Bias | 1 | 2012 | 1 | 0.390 |
Why?
|
| Arthralgia | 1 | 2012 | 12 | 0.390 |
Why?
|
| Anesthesia, Local | 1 | 2011 | 2 | 0.390 |
Why?
|
| Ovariectomy | 1 | 2011 | 6 | 0.390 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2011 | 1 | 0.390 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2011 | 3 | 0.380 |
Why?
|
| Electroencephalography | 1 | 2011 | 9 | 0.380 |
Why?
|
| Nervous System Diseases | 1 | 2011 | 4 | 0.380 |
Why?
|
| Medication Errors | 1 | 2011 | 2 | 0.370 |
Why?
|
| Anesthesia, Conduction | 1 | 2011 | 1 | 0.370 |
Why?
|
| Ovarian Neoplasms | 1 | 2011 | 1 | 0.370 |
Why?
|
| Postoperative Care | 1 | 2011 | 1 | 0.370 |
Why?
|
| Risk Factors | 6 | 2018 | 150 | 0.360 |
Why?
|
| Cohort Studies | 6 | 2018 | 118 | 0.360 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2014 | 8 | 0.340 |
Why?
|
| Rest | 3 | 2015 | 5 | 0.320 |
Why?
|
| Movement | 3 | 2015 | 11 | 0.320 |
Why?
|
| Labor, Obstetric | 2 | 2018 | 2 | 0.290 |
Why?
|
| Intraoperative Complications | 2 | 2018 | 3 | 0.290 |
Why?
|
| Osteotomy | 2 | 2018 | 4 | 0.290 |
Why?
|
| Osteoarthritis, Knee | 2 | 2018 | 21 | 0.290 |
Why?
|
| Radiculopathy | 2 | 2017 | 2 | 0.280 |
Why?
|
| Follow-Up Studies | 4 | 2019 | 76 | 0.280 |
Why?
|
| Severity of Illness Index | 3 | 2015 | 63 | 0.280 |
Why?
|
| China | 2 | 2018 | 6 | 0.270 |
Why?
|
| Thoracic Vertebrae | 2 | 2017 | 2 | 0.270 |
Why?
|
| Catheters, Indwelling | 2 | 2017 | 2 | 0.260 |
Why?
|
| Leadership | 2 | 2019 | 19 | 0.260 |
Why?
|
| Placebos | 2 | 2017 | 7 | 0.260 |
Why?
|
| Pharyngitis | 2 | 2017 | 4 | 0.250 |
Why?
|
| Labor Pain | 2 | 2018 | 2 | 0.250 |
Why?
|
| Internet | 2 | 2015 | 8 | 0.250 |
Why?
|
| Administration, Oral | 2 | 2017 | 10 | 0.250 |
Why?
|
| Pain Threshold | 3 | 2014 | 3 | 0.240 |
Why?
|
| Career Choice | 2 | 2016 | 5 | 0.230 |
Why?
|
| Age Distribution | 2 | 2015 | 5 | 0.230 |
Why?
|
| Odds Ratio | 2 | 2015 | 14 | 0.220 |
Why?
|
| Cough | 2 | 2013 | 4 | 0.220 |
Why?
|
| Sample Size | 2 | 2015 | 2 | 0.220 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 97 | 0.210 |
Why?
|
| Sensitivity and Specificity | 3 | 2018 | 47 | 0.210 |
Why?
|
| Faculty | 2 | 2013 | 15 | 0.210 |
Why?
|
| Electric Stimulation | 2 | 2013 | 23 | 0.200 |
Why?
|
| Education, Medical, Graduate | 2 | 2012 | 15 | 0.200 |
Why?
|
| Peer Review, Research | 2 | 2012 | 3 | 0.200 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2012 | 8 | 0.200 |
Why?
|
| Patient Discharge | 2 | 2012 | 12 | 0.190 |
Why?
|
| Blood Coagulation Factors | 2 | 2019 | 6 | 0.190 |
Why?
|
| Partial Thromboplastin Time | 2 | 2019 | 2 | 0.190 |
Why?
|
| Anticoagulants | 2 | 2019 | 16 | 0.190 |
Why?
|
| Chronic Disease | 2 | 2011 | 17 | 0.190 |
Why?
|
| Predictive Value of Tests | 3 | 2019 | 38 | 0.190 |
Why?
|
| Propensity Score | 2 | 2018 | 2 | 0.190 |
Why?
|
| Case-Control Studies | 2 | 2018 | 45 | 0.180 |
Why?
|
| Single-Blind Method | 3 | 2017 | 10 | 0.180 |
Why?
|
| Neck Pain | 2 | 2017 | 2 | 0.170 |
Why?
|
| Tibia | 2 | 2018 | 23 | 0.170 |
Why?
|
| Blood Gas Analysis | 2 | 2018 | 2 | 0.170 |
Why?
|
| Metformin | 1 | 2020 | 3 | 0.170 |
Why?
|
| Complex Regional Pain Syndromes | 1 | 2020 | 3 | 0.170 |
Why?
|
| Time-to-Treatment | 1 | 2020 | 4 | 0.170 |
Why?
|
| Edema | 1 | 2020 | 4 | 0.170 |
Why?
|
| Infusions, Intravenous | 3 | 2018 | 8 | 0.170 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2019 | 4 | 0.160 |
Why?
|
| Injections, Intravenous | 3 | 2015 | 5 | 0.160 |
Why?
|
| Patient Satisfaction | 2 | 2016 | 9 | 0.160 |
Why?
|
| Prothrombin Time | 1 | 2019 | 1 | 0.160 |
Why?
|
| Blood Coagulation Tests | 1 | 2019 | 3 | 0.160 |
Why?
|
| Injections, Spinal | 4 | 2017 | 5 | 0.160 |
Why?
|
| Blood Coagulation | 1 | 2019 | 5 | 0.160 |
Why?
|
| Prostate | 1 | 2019 | 1 | 0.160 |
Why?
|
| Prostate-Specific Antigen | 1 | 2019 | 1 | 0.160 |
Why?
|
| Endosonography | 1 | 2019 | 1 | 0.160 |
Why?
|
| Image-Guided Biopsy | 1 | 2019 | 1 | 0.160 |
Why?
|
| Prostatic Neoplasms | 1 | 2019 | 2 | 0.160 |
Why?
|
| Administration, Intravenous | 2 | 2017 | 4 | 0.160 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 6 | 0.160 |
Why?
|
| Radiography | 2 | 2016 | 35 | 0.160 |
Why?
|
| Blood Coagulation Disorders | 2 | 2019 | 2 | 0.160 |
Why?
|
| Anesthesiologists | 1 | 2019 | 1 | 0.160 |
Why?
|
| Women, Working | 1 | 2019 | 1 | 0.160 |
Why?
|
| Sexism | 1 | 2019 | 3 | 0.160 |
Why?
|
| Physicians, Women | 1 | 2019 | 4 | 0.160 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 17 | 0.160 |
Why?
|
| Ephedrine | 2 | 2018 | 2 | 0.160 |
Why?
|
| Pain Perception | 1 | 2018 | 1 | 0.160 |
Why?
|
| Bone Plates | 1 | 2018 | 1 | 0.150 |
Why?
|
| Osteosarcoma | 1 | 2018 | 4 | 0.150 |
Why?
|
| International Normalized Ratio | 1 | 2018 | 2 | 0.150 |
Why?
|
| Warfarin | 1 | 2018 | 2 | 0.150 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 35 | 0.150 |
Why?
|
| Bone Neoplasms | 1 | 2018 | 11 | 0.150 |
Why?
|
| Anesthesia, Spinal | 1 | 2018 | 1 | 0.150 |
Why?
|
| Phenylephrine | 1 | 2018 | 1 | 0.150 |
Why?
|
| Umbilical Arteries | 1 | 2018 | 1 | 0.150 |
Why?
|
| Pre-Exposure Prophylaxis | 1 | 2018 | 1 | 0.150 |
Why?
|
| Pre-Eclampsia | 1 | 2018 | 2 | 0.150 |
Why?
|
| Infant, Newborn | 1 | 2018 | 55 | 0.150 |
Why?
|
| Pregnancy Outcome | 2 | 2015 | 5 | 0.150 |
Why?
|
| Drug Delivery Systems | 1 | 2018 | 2 | 0.150 |
Why?
|
| Young Adult | 2 | 2015 | 157 | 0.150 |
Why?
|
| Muscle Weakness | 1 | 2017 | 2 | 0.150 |
Why?
|
| Breech Presentation | 1 | 2017 | 1 | 0.140 |
Why?
|
| Version, Fetal | 1 | 2017 | 1 | 0.140 |
Why?
|
| Denervation | 1 | 2017 | 1 | 0.140 |
Why?
|
| Deglutition Disorders | 1 | 2017 | 1 | 0.140 |
Why?
|
| Hoarseness | 1 | 2017 | 1 | 0.140 |
Why?
|
| Breast Feeding | 1 | 2017 | 14 | 0.140 |
Why?
|
| Lung Diseases | 1 | 2017 | 3 | 0.140 |
Why?
|
| Body Weight | 1 | 2017 | 15 | 0.140 |
Why?
|
| Injections | 2 | 2014 | 4 | 0.140 |
Why?
|
| Steroids | 1 | 2017 | 3 | 0.140 |
Why?
|
| Cervical Vertebrae | 1 | 2017 | 7 | 0.140 |
Why?
|
| Obesity | 1 | 2017 | 24 | 0.140 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2016 | 2 | 0.140 |
Why?
|
| Intracranial Aneurysm | 1 | 2016 | 6 | 0.140 |
Why?
|
| Patellar Dislocation | 1 | 2016 | 1 | 0.140 |
Why?
|
| Anterior Cruciate Ligament | 1 | 2016 | 3 | 0.140 |
Why?
|
| Databases, Factual | 2 | 2015 | 10 | 0.130 |
Why?
|
| Specimen Handling | 1 | 2016 | 4 | 0.130 |
Why?
|
| Combined Modality Therapy | 2 | 2016 | 20 | 0.130 |
Why?
|
| Blood Transfusion | 1 | 2016 | 3 | 0.130 |
Why?
|
| Probability | 1 | 2016 | 5 | 0.130 |
Why?
|
| Academies and Institutes | 1 | 2016 | 2 | 0.130 |
Why?
|
| Health Surveys | 1 | 2015 | 9 | 0.130 |
Why?
|
| Physical Examination | 1 | 2015 | 7 | 0.130 |
Why?
|
| Sacroiliac Joint | 1 | 2015 | 2 | 0.130 |
Why?
|
| Scoliosis | 1 | 2015 | 2 | 0.130 |
Why?
|
| Placenta Diseases | 1 | 2015 | 1 | 0.130 |
Why?
|
| Blood Patch, Epidural | 1 | 2015 | 1 | 0.120 |
Why?
|
| Breast | 1 | 2015 | 2 | 0.120 |
Why?
|
| Protective Factors | 1 | 2015 | 6 | 0.120 |
Why?
|
| Postoperative Period | 1 | 2015 | 4 | 0.120 |
Why?
|
| Catheters | 1 | 2015 | 4 | 0.120 |
Why?
|
| Biopsy | 1 | 2015 | 12 | 0.120 |
Why?
|
| Labor Stage, Third | 1 | 2015 | 1 | 0.120 |
Why?
|
| Labor, Induced | 1 | 2015 | 1 | 0.120 |
Why?
|
| Oxytocics | 1 | 2015 | 1 | 0.120 |
Why?
|
| Oxytocin | 1 | 2015 | 1 | 0.120 |
Why?
|
| Placenta | 1 | 2015 | 1 | 0.120 |
Why?
|
| Uterine Inertia | 1 | 2015 | 1 | 0.120 |
Why?
|
| Illinois | 1 | 2015 | 16 | 0.120 |
Why?
|
| Joint Dislocations | 1 | 2015 | 8 | 0.120 |
Why?
|
| Patient Compliance | 1 | 2015 | 10 | 0.120 |
Why?
|
| Informed Consent | 1 | 2015 | 7 | 0.120 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2015 | 1 | 0.120 |
Why?
|
| Patient Education as Topic | 1 | 2015 | 10 | 0.120 |
Why?
|
| Liver | 1 | 2015 | 8 | 0.120 |
Why?
|
| Liver Cirrhosis | 1 | 2015 | 5 | 0.120 |
Why?
|
| Necrosis | 1 | 2015 | 2 | 0.120 |
Why?
|
| Mucous Membrane | 1 | 2015 | 2 | 0.120 |
Why?
|
| Fatal Outcome | 1 | 2015 | 4 | 0.120 |
Why?
|
| Operative Time | 1 | 2015 | 3 | 0.120 |
Why?
|
| Venous Thromboembolism | 1 | 2015 | 3 | 0.120 |
Why?
|
| Databases, Bibliographic | 1 | 2015 | 1 | 0.120 |
Why?
|
| Hospitals, Urban | 1 | 2014 | 2 | 0.120 |
Why?
|
| Adolescent | 1 | 2015 | 210 | 0.120 |
Why?
|
| Calcinosis | 1 | 2014 | 1 | 0.120 |
Why?
|
| Lameness, Animal | 1 | 2014 | 1 | 0.120 |
Why?
|
| High-Energy Shock Waves | 1 | 2014 | 1 | 0.120 |
Why?
|
| Forelimb | 1 | 2014 | 2 | 0.120 |
Why?
|
| Sex Factors | 1 | 2015 | 44 | 0.120 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 2014 | 1 | 0.120 |
Why?
|
| Pulmonary Embolism | 1 | 2015 | 8 | 0.120 |
Why?
|
| Venous Thrombosis | 1 | 2015 | 9 | 0.120 |
Why?
|
| Pilot Projects | 1 | 2014 | 37 | 0.120 |
Why?
|
| Pregnancy Complications | 1 | 2014 | 5 | 0.120 |
Why?
|
| Inflammation | 1 | 2014 | 17 | 0.120 |
Why?
|
| Anxiety | 1 | 2014 | 15 | 0.120 |
Why?
|
| Ultrasonography | 2 | 2014 | 70 | 0.110 |
Why?
|
| Hot Temperature | 1 | 2014 | 1 | 0.110 |
Why?
|
| Cold Temperature | 1 | 2014 | 2 | 0.110 |
Why?
|
| Preoperative Care | 1 | 2014 | 3 | 0.110 |
Why?
|
| Abdominal Muscles | 1 | 2014 | 1 | 0.110 |
Why?
|
| Hemodynamics | 2 | 2013 | 4 | 0.110 |
Why?
|
| Mammaplasty | 1 | 2014 | 1 | 0.110 |
Why?
|
| Regression Analysis | 1 | 2014 | 17 | 0.110 |
Why?
|
| Anesthetics, Combined | 1 | 2013 | 1 | 0.110 |
Why?
|
| Wound Healing | 1 | 2013 | 6 | 0.110 |
Why?
|
| Motor Activity | 1 | 2013 | 21 | 0.110 |
Why?
|
| Laryngismus | 1 | 2013 | 1 | 0.110 |
Why?
|
| Population Density | 1 | 2013 | 1 | 0.110 |
Why?
|
| Vasectomy | 1 | 2013 | 1 | 0.110 |
Why?
|
| Euthanasia, Animal | 1 | 2013 | 1 | 0.110 |
Why?
|
| Animals, Wild | 1 | 2013 | 2 | 0.110 |
Why?
|
| Shivering | 1 | 2013 | 1 | 0.110 |
Why?
|
| Endpoint Determination | 1 | 2013 | 2 | 0.110 |
Why?
|
| Headache | 1 | 2013 | 7 | 0.110 |
Why?
|
| Computer Simulation | 1 | 2013 | 30 | 0.110 |
Why?
|
| Dizziness | 1 | 2013 | 4 | 0.110 |
Why?
|
| Prevalence | 1 | 2013 | 28 | 0.110 |
Why?
|
| Survival Rate | 2 | 2011 | 9 | 0.110 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2013 | 2 | 0.110 |
Why?
|
| Health Care Surveys | 1 | 2013 | 8 | 0.100 |
Why?
|
| Work Schedule Tolerance | 1 | 2013 | 6 | 0.100 |
Why?
|
| Efficiency | 1 | 2012 | 2 | 0.100 |
Why?
|
| Data Collection | 1 | 2012 | 5 | 0.100 |
Why?
|
| Stomach Neoplasms | 1 | 2012 | 5 | 0.100 |
Why?
|
| Lymph Nodes | 1 | 2012 | 5 | 0.100 |
Why?
|
| Aging | 1 | 2013 | 79 | 0.100 |
Why?
|
| Foreign Medical Graduates | 1 | 2012 | 1 | 0.100 |
Why?
|
| Licensure, Medical | 1 | 2012 | 1 | 0.100 |
Why?
|
| Specialty Boards | 1 | 2012 | 1 | 0.100 |
Why?
|
| Authorship | 1 | 2012 | 6 | 0.100 |
Why?
|
| Sex Distribution | 1 | 2012 | 6 | 0.100 |
Why?
|
| Hypotension | 1 | 2012 | 4 | 0.100 |
Why?
|
| Analgesia, Patient-Controlled | 1 | 2012 | 1 | 0.100 |
Why?
|
| Range of Motion, Articular | 1 | 2012 | 16 | 0.100 |
Why?
|
| Diskectomy | 1 | 2012 | 4 | 0.100 |
Why?
|
| Length of Stay | 1 | 2012 | 7 | 0.100 |
Why?
|
| Bradycardia | 1 | 2012 | 3 | 0.100 |
Why?
|
| Intervertebral Disc | 1 | 2012 | 6 | 0.100 |
Why?
|
| Guideline Adherence | 1 | 2012 | 1 | 0.100 |
Why?
|
| Longitudinal Studies | 1 | 2012 | 78 | 0.100 |
Why?
|
| Likelihood Functions | 1 | 2012 | 5 | 0.100 |
Why?
|
| Myocardial Infarction | 1 | 2012 | 7 | 0.100 |
Why?
|
| Atrial Fibrillation | 1 | 2012 | 8 | 0.100 |
Why?
|
| Multicenter Studies as Topic | 1 | 2012 | 7 | 0.100 |
Why?
|
| Research Support as Topic | 1 | 2012 | 2 | 0.100 |
Why?
|
| Lumbar Vertebrae | 1 | 2012 | 27 | 0.100 |
Why?
|
| Models, Statistical | 1 | 2012 | 20 | 0.100 |
Why?
|
| Bibliometrics | 1 | 2012 | 5 | 0.100 |
Why?
|
| Research Design | 1 | 2012 | 15 | 0.100 |
Why?
|
| Sterilization, Reproductive | 1 | 2011 | 1 | 0.100 |
Why?
|
| Urinary Incontinence | 1 | 2011 | 3 | 0.100 |
Why?
|
| Clinical Trials as Topic | 1 | 2012 | 23 | 0.100 |
Why?
|
| Equipment Failure Analysis | 1 | 2011 | 6 | 0.100 |
Why?
|
| Equipment Design | 1 | 2011 | 12 | 0.100 |
Why?
|
| Preanesthetic Medication | 1 | 2011 | 1 | 0.100 |
Why?
|
| Abdomen | 1 | 2011 | 3 | 0.100 |
Why?
|
| Piperidines | 1 | 2011 | 4 | 0.100 |
Why?
|
| Tendons | 1 | 2011 | 1 | 0.100 |
Why?
|
| Ankle | 1 | 2011 | 2 | 0.100 |
Why?
|
| Foot | 1 | 2011 | 2 | 0.100 |
Why?
|
| Arthroscopy | 1 | 2011 | 4 | 0.090 |
Why?
|
| Treatment Failure | 1 | 2011 | 9 | 0.090 |
Why?
|
| Orthopedic Procedures | 1 | 2011 | 3 | 0.090 |
Why?
|
| Drug Recalls | 1 | 2011 | 1 | 0.090 |
Why?
|
| Carcinoma | 1 | 2011 | 2 | 0.090 |
Why?
|
| Pancreatic Neoplasms | 1 | 2011 | 3 | 0.090 |
Why?
|
| Neuroendocrine Tumors | 1 | 2011 | 2 | 0.090 |
Why?
|
| Secondary Prevention | 1 | 2011 | 2 | 0.090 |
Why?
|
| Monoamine Oxidase Inhibitors | 2 | 1987 | 2 | 0.080 |
Why?
|
| Mice | 2 | 2020 | 219 | 0.080 |
Why?
|
| Prognosis | 2 | 2018 | 30 | 0.070 |
Why?
|
| Injections, Epidural | 2 | 2017 | 2 | 0.070 |
Why?
|
| ROC Curve | 2 | 2019 | 12 | 0.070 |
Why?
|
| Risk Assessment | 2 | 2017 | 37 | 0.060 |
Why?
|
| Surgical Procedures, Operative | 1 | 1985 | 2 | 0.060 |
Why?
|
| Electroconvulsive Therapy | 1 | 1985 | 2 | 0.060 |
Why?
|
| Comprehension | 2 | 2015 | 4 | 0.060 |
Why?
|
| Cardiac Output | 1 | 2002 | 1 | 0.050 |
Why?
|
| Emulsions | 1 | 2002 | 1 | 0.050 |
Why?
|
| Respiratory System | 1 | 2002 | 1 | 0.050 |
Why?
|
| Phospholipids | 1 | 2002 | 4 | 0.050 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2002 | 1 | 0.050 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2002 | 2 | 0.050 |
Why?
|
| Indans | 1 | 2002 | 2 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2002 | 11 | 0.050 |
Why?
|
| Spinal Cord | 1 | 2002 | 7 | 0.050 |
Why?
|
| Sepsis | 1 | 2002 | 8 | 0.050 |
Why?
|
| Blood Pressure | 3 | 2002 | 16 | 0.050 |
Why?
|
| Tibial Fractures | 1 | 2020 | 2 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2020 | 3 | 0.040 |
Why?
|
| Random Allocation | 1 | 2020 | 12 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 57 | 0.040 |
Why?
|
| Lupus Coagulation Inhibitor | 1 | 2019 | 1 | 0.040 |
Why?
|
| Risk | 1 | 2019 | 23 | 0.040 |
Why?
|
| Rectum | 1 | 2019 | 2 | 0.040 |
Why?
|
| Thrombosis | 1 | 2019 | 8 | 0.040 |
Why?
|
| Stainless Steel | 1 | 2018 | 1 | 0.040 |
Why?
|
| Electrochemical Techniques | 1 | 2018 | 1 | 0.040 |
Why?
|
| Corrosion | 1 | 2018 | 3 | 0.040 |
Why?
|
| Surface Properties | 1 | 2018 | 17 | 0.040 |
Why?
|
| Materials Testing | 1 | 2018 | 16 | 0.040 |
Why?
|
| Education, Medical | 1 | 2019 | 22 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2018 | 26 | 0.040 |
Why?
|
| Quality of Life | 1 | 2018 | 31 | 0.040 |
Why?
|
| Triamcinolone Acetonide | 1 | 2017 | 1 | 0.040 |
Why?
|
| Arm | 1 | 2017 | 2 | 0.040 |
Why?
|
| Hand Strength | 1 | 2017 | 3 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2017 | 3 | 0.040 |
Why?
|
| Blood Loss, Surgical | 1 | 2016 | 1 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2016 | 3 | 0.030 |
Why?
|
| Aneurysm, Ruptured | 1 | 2016 | 5 | 0.030 |
Why?
|
| Cerebral Hemorrhage | 1 | 2016 | 5 | 0.030 |
Why?
|
| Stifle | 1 | 2016 | 2 | 0.030 |
Why?
|
| Age Factors | 1 | 2016 | 54 | 0.030 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2016 | 2 | 0.030 |
Why?
|
| Carbon Dioxide | 1 | 2016 | 4 | 0.030 |
Why?
|
| Oxygen | 1 | 2016 | 9 | 0.030 |
Why?
|
| Bone Screws | 1 | 2015 | 10 | 0.030 |
Why?
|
| Pregnancy Trimester, First | 1 | 2015 | 1 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2015 | 1 | 0.030 |
Why?
|
| Gestational Age | 1 | 2015 | 8 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2015 | 8 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2015 | 18 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2015 | 5 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2014 | 4 | 0.030 |
Why?
|
| Communication | 1 | 2014 | 14 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 13 | 0.030 |
Why?
|
| Anesthesia, Intravenous | 1 | 2014 | 1 | 0.030 |
Why?
|
| Heart Rate | 2 | 2002 | 13 | 0.030 |
Why?
|
| Axilla | 1 | 2013 | 1 | 0.030 |
Why?
|
| Lymph Node Excision | 1 | 2013 | 2 | 0.030 |
Why?
|
| Discriminant Analysis | 1 | 2012 | 2 | 0.030 |
Why?
|
| Hospitals, University | 1 | 2012 | 2 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2011 | 1 | 0.020 |
Why?
|
| Phantoms, Imaging | 1 | 2011 | 3 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2011 | 21 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2011 | 33 | 0.020 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 1987 | 1 | 0.020 |
Why?
|
| Drug Evaluation | 1 | 1985 | 1 | 0.020 |
Why?
|
| Pargyline | 1 | 1985 | 1 | 0.020 |
Why?
|
| Phenelzine | 1 | 1985 | 1 | 0.020 |
Why?
|
| Tranylcypromine | 1 | 1985 | 1 | 0.020 |
Why?
|
| Body Temperature | 1 | 1985 | 5 | 0.020 |
Why?
|
| Escherichia coli Infections | 1 | 2002 | 2 | 0.010 |
Why?
|
| Lipoproteins, HDL | 1 | 2002 | 2 | 0.010 |
Why?
|
| Swine | 1 | 2002 | 8 | 0.010 |
Why?
|
| Endotoxins | 1 | 2002 | 2 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2002 | 25 | 0.010 |
Why?
|
| Peritonitis | 1 | 2002 | 3 | 0.010 |
Why?
|
| Fetal Monitoring | 1 | 2002 | 1 | 0.010 |
Why?
|
| Heart Rate, Fetal | 1 | 2002 | 1 | 0.010 |
Why?
|
| Pruritus | 1 | 2002 | 1 | 0.010 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2002 | 1 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2002 | 4 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2002 | 5 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 2002 | 3 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2002 | 7 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2002 | 95 | 0.010 |
Why?
|
| Rats | 1 | 2002 | 160 | 0.010 |
Why?
|
| Enflurane | 1 | 1987 | 1 | 0.000 |
Why?
|
| Norepinephrine | 1 | 1987 | 3 | 0.000 |
Why?
|
| Drug Interactions | 1 | 1987 | 7 | 0.000 |
Why?
|